Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice
Aging · 2023
DOI: 10.18632/aging.205333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Weifeng Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Laizhou City People’s Hospital, Yantai, Shandong 261400, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Endoplasmic Reticulum Stress, Cognitive Dysfunction, Inflammasomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Laizhou City People’s Hospital, Yantai, Shandong 261400, China.
Zitieren
APA
Wang, W., & Zhang, J. (2023). Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice. Aging. https://doi.org/10.18632/aging.205333
Vancouver
Wang W, Zhang J. Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice. Aging. 2023. doi:10.18632/aging.205333
BibTeX
@article{Wang2023,
author = {Wang, Weifeng and Zhang, Juanjuan},
title = {Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205333}
}
EUVIMED